Prophylactic and Therapeutic Measures of Homeopathy in Epidemic and Pandemic Diseases

2021 ◽  
Author(s):  
Ghulam Yaseen
Keyword(s):  
Infectious Diseases ◽  
English Language ◽  
World Health Organisation ◽  
Relevant Information ◽  
World Health ◽  
Bibliographic Databases ◽  
Mortality And Morbidity ◽  
The World ◽  
Google Search ◽  
Epidemic Diseases

Abstract Background The terms ‘Epidemic’ and ‘Pandemic’ refer to spread of infectious diseases in different countries, nations or regions. Infectious diseases have overrun millions of people in the past, as well as present where the world is facing current coronavirus disease 2019 (Covid-19) pandemic, which has killed more than 607,781 people till July 2020, according to the World Health Organisation. Homeopathy has played an important role in controlling epidemic and pandemic diseases since the time of Hahnemann who cured scarlet fever with Belladonna and served community with best treatment. This article reviews the role of homeopathy in the management and prevention of pandemic and epidemic diseases. Methods A homeopathic literature search was performed using several bibliographic databases such as Google Scholar, PubMed and Google search engine was used for collection of all relevant information from reports, review articles, archived files and web pages etc., published in English language till July 2020. Results Gathered information based on scientific evidences manifested the efficacy of homeopathy using various approaches such as individualisation, Genus epidemicus and isopathy for prevention and treatment of epidemic diseases. Conclusion Homeopathy showcased its effectiveness in reduction of mortality and morbidity in epidemics for years. Moreover, prophylactic use of Genus epidemicus for symptomatic Covid-19 cases can be inexpensive, safe and more realistic.

Health Facilitation

1969 ◽  
Vol 73 (706) ◽  
pp. 864-868
Author(s):  
K. Bergin
Keyword(s):  
World Health Organisation ◽  
Daily Basis ◽  
World Health ◽  
Civil Aviation ◽  
Medical Problems ◽  
Medical Standards ◽  
International Civil Aviation Organisation ◽  
The World ◽  
The Uk ◽  
Epidemic Diseases

The organisations involved in health facilitation are 3 international ones, 1 national one and 1 local one. The three international ones are: (a) The World Health Organisation, an offshoot of the United Nations and before that the League of Nations. This body has headquarters at Geneva and disseminates on a daily basis, world-wide information on epidemic diseases, thus keeping countries fully informed of the current disease position in other countries. (b) The International Civil Aviation Organisation, which is a consortium of Government Agencies which draws up statutory regulations for the international control of air travel including, among others, personnel and medical problems. Its objective is to implement the Chicago Convention which, in turn, was the successor to the Paris Convention. It is obviously desirable that recommended practices of medical standards for pilots should be uniform throughout the world. Sir Frederick Tymms was at one time the UK representative. (c) The International Air Transport Association, a voluntary organisation of air operators which endeavours to regulate conditions among commercially competing airlines. The medical committee, like other committees, makes an annual report to the Executive. Sir Wjlliam Hildred was its distinguished chairman for many years.

scholarly journals 301 Theatre Timing Audit (TTA): HPB and Transplant theatre timing during COVID

2021 ◽  
Vol 108 (Supplement_6) ◽  
Author(s):  
Marios Ghobrial ◽  
Jos Crush ◽  
Igor Chipurovski ◽  
Fanourios Georgiades
Keyword(s):  
World Health Organisation ◽  
World Health ◽  
P Value ◽  
Anaesthetic Induction ◽  
Mortality And Morbidity ◽  
Morbidity Burden ◽  
Period 2 ◽  
The World ◽  
The Uk ◽  
The Impact

Abstract Introduction Severe-Acute-Respiratory-Syndrome-Coronavirus-2 is a novel, highly infectious virus that has spread throughout the world causing respiratory disease (COVID-19). COVID-19 was declared a global pandemic by the World Health Organisation in March 2020. The UK has been severely affected with around 70000 deaths recorded by December 2020. Surgical practice during this pandemic has changed, as peri-operative infections carry significant mortality and morbidity burden. Method Theatre timing from a large volume hospital specifically for HPB-Transplant dedicated theatres were assessed to evaluate the impact of the national/local COVID-19 protocols on service delivery. “Pre-COVID period” was defined by auditing times from ward-to-theatre, anaesthetic induction-to-start of procedure and end of procedure-to-transfer out of theatre for 2 consecutive weeks in October/November 2019. “COVID period-1” and “COVID period-2” were defined as two consecutive weeks during the UK government-imposed lockdown in April and November 2020, respectively. Results Under the care of the HPB-Transplant team pre-COVID 56 individuals were treated in 30 sessions. Only 16 patients (28.6% of capacity) in 12 sessions were treated in COVID period-1 and 48 patients were treated (85.7% of capacity) in 30 sessions in COVID period-2. Similar times were observed in transferring patients to theatre (p-value=0.265) and induction of anaesthesia (p-value=0.698) across the 3 periods. Significant delays were observed in transferring patients out of theatre during COVID period-1, that returned to near normal timing during COVID period-2 (16.6±12.8 Vs 39.4±10.9 Vs 17.6±10.5 min; p-value = <0.00001). Conclusions Despite returning to near normal theatre timings in COVID period-2, we treat fewer patients, adversely affecting waiting lists.

A Collaborative Study to Establish the Second International Standard for Streptokinase

1990 ◽  
Vol 64 (02) ◽  
pp. 267-269 ◽  
Author(s):  
A B Heath ◽  
P J Gaffney
Keyword(s):  
High Purity ◽  
Collaborative Study ◽  
World Health Organisation ◽  
World Health ◽  
Clot Lysis ◽  
Current Standard ◽  
International Standard ◽  
Accelerated Degradation ◽  
The World ◽  
International Collaborative Study

SummaryAn International Standard for Streptokinase - Streptodomase (62/7) has been used to calibrate high purity clinical batches of SK since 1965. An international collaborative study, involving six laboratories, was undertaken to replace this standard with a high purity standard for SK. Two candidate preparations (88/826 and 88/824) were compared by a clot lysis assay with the current standard (62/7). Potencies of 671 i.u. and 461 i.u. were established for preparations A (88/826) and B (88/824), respectively.Either preparation appeared suitable to serve as a standard for SK. However, each ampoule of preparation A (88/826) contains a more appropriate amount of SK activity for potency testing, and is therefore preferred. Accelerated degradation tests indicate that preparation A (88/826) is very stable.The high purity streptokinase preparation, coded 88/826, has been established by the World Health Organisation as the 2nd International Standard for Streptokinase, with an assigned potency of 700 i.u. per ampoule.

Comparative docking of SARS-CoV-2 receptors antagonists from repurposing drugs

2020 ◽  
Author(s):  
Micael Davi Lima de Oliveira ◽  
Kelson Mota Teixeira de Oliveira
Keyword(s):  
World Health Organisation ◽  
World Health ◽  
Lung Cells ◽  
The Novel ◽  
High Modulation ◽  
Main Protease ◽  
The World ◽  
Novel Coronavirus ◽  
Viral Receptors ◽  
Theoretical Results

According to the World Health Organisation, until 16 June, 2020, the number of confirmed and notified cases of COVID-19 has already exceeded 7.9 million with approximately 434 thousand deaths worldwide. This research aimed to find repurposing antagonists, that may inhibit the activity of the main protease (Mpro) of the SARS-CoV-2 virus, as well as partially modulate the ACE2 receptors largely found in lung cells, and reduce viral replication by inhibiting Nsp12 RNA polymerase. Docking molecular simulations were performed among a total of 60 structures, most of all, published in the literature against the novel coronavirus. The theoretical results indicated that, in comparative terms, paritaprevir, ivermectin, ledipasvir, and simeprevir, are among the most theoretical promising drugs in remission of symptoms from the disease. Furthermore, also corroborate indinavir to the high modulation in viral receptors. The second group of promising drugs includes remdesivir and azithromycin. The repurposing drugs HCQ and chloroquine were not effective in comparative terms to other drugs, as monotherapies, against SARS-CoV-2 infection.

Organization of restrictive quarantine measures to prevent especially dangerous infections

2020 ◽  
pp. 6-11
Author(s):  
Petr Ilyin
Keyword(s):  
Infectious Diseases ◽  
Clinical Symptoms ◽  
International Health ◽  
World Health ◽  
The World ◽  
History Of ◽  
Entire History ◽  
Health Organization ◽  
Former Ussr ◽  
Health Regulations

Especially dangerous infections (EDIs) belong to the conditionally labelled group of infectious diseases that pose an exceptional epidemic threat. They are highly contagious, rapidly spreading and capable of affecting wide sections of the population in the shortest possible time, they are characterized by the severity of clinical symptoms and high mortality rates. At the present stage, the term "especially dangerous infections" is used only in the territory of the countries of the former USSR, all over the world this concept is defined as "infectious diseases that pose an extreme threat to public health on an international scale." Over the entire history of human development, more people have died as a result of epidemics and pandemics than in all wars combined. The list of especially dangerous infections and measures to prevent their spread were fixed in the International Health Regulations (IHR), adopted at the 22nd session of the WHO's World Health Assembly on July 26, 1969. In 1970, at the 23rd session of the WHO's Assembly, typhus and relapsing fever were excluded from the list of quarantine infections. As amended in 1981, the list included only three diseases represented by plague, cholera and anthrax. However, now annual additions of new infections endemic to different parts of the earth to this list take place. To date, the World Health Organization (WHO) has already included more than 100 diseases in the list of especially dangerous infections.

Use of Phosphatidylcholine in the Treatment of Localized Fat Deposits. Results and expectations

2017 ◽  
Vol 68 (7) ◽  
pp. 1438-1441 ◽  
Author(s):  
Sorin Berbece ◽  
Dan Iliescu ◽  
Valeriu Ardeleanu ◽  
Alexandru Nicolau ◽  
Radu Cristian Jecan
Keyword(s):  
World Health Organisation ◽  
Normal Weight ◽  
World Health ◽  
Basic Substance ◽  
Physical Exercises ◽  
Fat Deposits ◽  
The World ◽  
The Common ◽  
Global Health Problem ◽  
Over Time

Obesity represents a global health problem. According to the latest studies released by the World Health Organisation (WHO), 1.7 billion currently in excess of normal weight individuals, of which approx. 75% are overweight (body mass index - BMI 25 to 30). The common form of excess adipose tissue manifestation in overweight individuals is localized fat deposits with high (abdominal) or low (buttocks and thighs) disposition. Although the overweight can be corrected relatively easy by changing behavioral habits or food, a constant physical exercises program or following a diet food are not accessible to all through the efforts of will, financial and time involved. Several methods have been studied and tested over time to eliminate more or less invasive fat deposits with varying efficacy and adverse effects. Chemical lipolysis using phosphatidylcholine as the basic substance was initially used in hypercholesterolemia and its complications and was rapidly adopted in mesotherapy techniques for the treatment of fat deposits. This study reveals the results obtained using Dermastabilon on a sample of 16 patients, the time allocated to treatment and discomfort being minimal, and rapid and notable results. There were no side effects.

The Undiscovered Potential of Essential Oils for Treating SARS-CoV-2 (COVID-19)

2020 ◽  
Vol 26 (41) ◽  
pp. 5261-5277
Author(s):  
Peter J. Wilkin ◽  
Minnatallah Al-Yozbaki ◽  
Alex George ◽  
Girish K. Gupta ◽  
Cornelia M. Wilson
Keyword(s):  
Essential Oils ◽  
Clinical Symptoms ◽  
Synergistic Effects ◽  
World Health Organisation ◽  
Diagnostic Techniques ◽  
World Health ◽  
Clinical Aspects ◽  
Traditional Use ◽  
In Silico Studies ◽  
The World

On 11th March 2020, the World Health Organisation (WHO) announced a pandemic caused by a novel beta-coronavirus SARS-CoV-2, designated COVID-19. The virus emerged in December 2019 in Wuhan, China, has spread across the world as a global pandemic. The traditional use of medicines from plants can be traced back to 60,000 years. Global interest in the development of drugs from natural products has increased greatly during the last few decades. Essential oils (EOs) have been studied through the centuries and are known to possess various pharmaceutical properties. In the present review, we have highlighted the current biology, epidemiology, various clinical aspects, different diagnostic techniques, clinical symptoms, and management of COVID-19. An overview of the antiviral action of EOs, along with their proposed mechanism of action and in silico studies conducted, is described. The reported studies of EOs' antiviral activity highlight the baseline data about the additive and/or synergistic effects among primary or secondary phytoconstituents found in individual oils, combinations or blends of oils and between EOs and antiviral drugs. It is hoped that further research will provide better insights into EOs' potential to limit viral infection and aid in providing solutions through natural, therapeutically active agents.

Infodemiological patterns in searching medication errors: relationship with risk management and shift work (Preprint)

2019 ◽  
Author(s):  
Fabio Fabbian ◽  
Emanuele Di Simone ◽  
Sara Dionisi ◽  
Noemi Giannetta ◽  
Luigi De Gennaro ◽  
...  
Keyword(s):  
Health Care ◽  
Risk Management ◽  
Shift Work ◽  
Medication Errors ◽  
Medical Errors ◽  
World Health ◽  
Noncommunicable Diseases ◽  
Western World ◽  
The World ◽  
Google Search

BACKGROUND Western world health care systems have been trying to improve their efficiency and effectiveness in order to respond properly to the aging of the population and the epidemic of noncommunicable diseases. Errors in drugs administration is an actual important issue due to different causes. OBJECTIVE Aim of this study is to measure interest in online seeking medical errors information online related to interest in risk management and shift work. METHODS We investigated Google Trends® for popular search relating to medical errors, risk management and shift work. Relative search volumes (RSVs) were evaluated for the period November 2008-November 2018 all around the world. A comparison between RSV curves related to medical errors, risk management and shift work was carried out. Then we compared world to Italian search. RESULTS RSVs were persistently higher for risk management than for medication errors during the study period (mean RSVs 74 vs. 51%) and RSVs were stably higher for medical errors than shift work during the study period (mean RSVs 51 vs 23%). In Italy, RSVs were much lower than the rest of the world, and RSVs for medication errors during the study period were negligible. Mean RSVs for risk management and shift work were 3 and 25%, respectively. RSVs related to medication errors and clinical risk management were correlated (r=0.520, p<0.0001). CONCLUSIONS Google search query volumes related to medication errors, risk management and shift work are different. RSVs for risk management are higher, are correlated with medication errors, and the relationship with shift work appears to be even worse, by analyzing the entire world. In Italy such a relationship completely disappears, suggesting that it needs to be emphasized by health care authorities.

Sign in / Sign up

Export Citation Format

Share Document